The Pharmaceutical Research and Manufacturers of America, an organisation that represents innovative biopharmaceutical research companies, announced yesterday that it has named Lori M Reilly, Esq as its new chief operating officer.

The new chief operating officer has been at the company for around 20 years, most recently serving as executive vice president of policy, research and membership. Prior to joining the company, Reilly spent several years on Capitol Hill working as a counsel for the House Energy and Commerce Committee and as counsel for a member of the House Ways and Means Committee.

In this newly created role, Reilly will offer executive level management, leadership and strategic direction to PhRMA and manage the association's federal, state and international government affairs and alliance development.